ID SCG2_HUMAN Reviewed; 617 AA. AC P13521; B2R662; Q53T11; Q8TBH3; DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot. DT 03-APR-2007, sequence version 2. DT 24-JAN-2024, entry version 189. DE RecName: Full=Secretogranin-2; DE AltName: Full=Chromogranin-C; DE AltName: Full=Secretogranin II; DE Short=SgII; DE Contains: DE RecName: Full=Secretoneurin; DE Short=SN; DE Contains: DE RecName: Full=Manserin; DE Flags: Precursor; GN Name=SCG2; Synonyms=CHGC; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND SULFATION AT TYR-151. RC TISSUE=Pituitary; RX PubMed=2745426; DOI=10.1016/s0021-9258(18)80167-3; RA Gerdes H.-H., Rosa P., Phillips E., Baeuerle P.A., Frank R., Argos P., RA Huttner W.B.; RT "The primary structure of human secretogranin II, a widespread tyrosine- RT sulfated secretory granule protein that exhibits low pH- and calcium- RT induced aggregation."; RL J. Biol. Chem. 264:12009-12015(1989). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Caudate nucleus; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLY-294; GLY-421 AND RP GLY-535. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP NUCLEOTIDE SEQUENCE [MRNA] OF 182-214. RX PubMed=9654353; DOI=10.1016/s0304-3940(98)00345-0; RA Leitner B., Schneitler C., Klocker H., Volknandt W., Zimmermann H., RA Winkler H., Fischer-Colbrie R.; RT "Formation and sequence analysis of secretoneurin, a neuropeptide derived RT from secretogranin II, in mammalian, bird, reptile, amphibian and fish RT brains."; RL Neurosci. Lett. 248:105-108(1998). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Pituitary; RX PubMed=16807684; DOI=10.1007/s11102-006-8916-x; RA Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.; RT "Phosphoproteomic analysis of the human pituitary."; RL Pituitary 9:109-120(2006). RN [8] RP INTERACTION WITH SCG3, AND FUNCTION. RX PubMed=19357184; DOI=10.1677/joe-08-0531; RA Hotta K., Hosaka M., Tanabe A., Takeuchi T.; RT "Secretogranin II binds to secretogranin III and forms secretory granules RT with orexin, neuropeptide Y, and POMC."; RL J. Endocrinol. 202:111-121(2009). RN [9] RP GLYCOSYLATION, AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=23234360; DOI=10.1021/pr300963h; RA Halim A., Ruetschi U., Larson G., Nilsson J.; RT "LC-MS/MS characterization of O-glycosylation sites and glycan structures RT of human cerebrospinal fluid glycoproteins."; RL J. Proteome Res. 12:573-584(2013). CC -!- FUNCTION: Neuroendocrine protein of the granin family that regulates CC the biogenesis of secretory granules. {ECO:0000269|PubMed:19357184}. CC -!- SUBUNIT: Interacts with Secretogranin III/SCG3. CC {ECO:0000269|PubMed:19357184}. CC -!- INTERACTION: CC P13521; Q8WXE1: ATRIP; NbExp=3; IntAct=EBI-947132, EBI-747353; CC P13521; Q9UMX0: UBQLN1; NbExp=4; IntAct=EBI-947132, EBI-741480; CC -!- SUBCELLULAR LOCATION: Secreted. Note=Neuroendocrine and endocrine CC secretory granules. CC -!- PTM: O-glycosylated. {ECO:0000269|PubMed:23234360}. CC -!- MISCELLANEOUS: Binds calcium with a low-affinity. CC -!- SIMILARITY: Belongs to the chromogranin/secretogranin protein family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M25756; AAA36607.1; -; mRNA. DR EMBL; AK312452; BAG35359.1; -; mRNA. DR EMBL; AC012512; AAY24243.1; -; Genomic_DNA. DR EMBL; CH471063; EAW70811.1; -; Genomic_DNA. DR EMBL; BC022509; AAH22509.1; -; mRNA. DR CCDS; CCDS2457.1; -. DR PIR; A34174; A34174. DR RefSeq; NP_003460.2; NM_003469.4. DR AlphaFoldDB; P13521; -. DR SMR; P13521; -. DR BioGRID; 113611; 14. DR CORUM; P13521; -. DR IntAct; P13521; 10. DR MINT; P13521; -. DR STRING; 9606.ENSP00000304133; -. DR iPTMnet; P13521; -. DR PhosphoSitePlus; P13521; -. DR BioMuta; SCG2; -. DR DMDM; 143811457; -. DR jPOST; P13521; -. DR MassIVE; P13521; -. DR MaxQB; P13521; -. DR PaxDb; 9606-ENSP00000304133; -. DR PeptideAtlas; P13521; -. DR ProteomicsDB; 52923; -. DR Antibodypedia; 2205; 377 antibodies from 34 providers. DR DNASU; 7857; -. DR Ensembl; ENST00000305409.3; ENSP00000304133.2; ENSG00000171951.5. DR GeneID; 7857; -. DR KEGG; hsa:7857; -. DR MANE-Select; ENST00000305409.3; ENSP00000304133.2; NM_003469.5; NP_003460.2. DR UCSC; uc002vnm.4; human. DR AGR; HGNC:10575; -. DR CTD; 7857; -. DR DisGeNET; 7857; -. DR GeneCards; SCG2; -. DR HGNC; HGNC:10575; SCG2. DR HPA; ENSG00000171951; Group enriched (adrenal gland, brain, pituitary gland). DR MIM; 118930; gene. DR neXtProt; NX_P13521; -. DR OpenTargets; ENSG00000171951; -. DR PharmGKB; PA34987; -. DR VEuPathDB; HostDB:ENSG00000171951; -. DR eggNOG; ENOG502QV5W; Eukaryota. DR GeneTree; ENSGT00390000010895; -. DR HOGENOM; CLU_031294_0_0_1; -. DR InParanoid; P13521; -. DR OMA; CVDAASF; -. DR OrthoDB; 5351720at2759; -. DR PhylomeDB; P13521; -. DR TreeFam; TF334018; -. DR PathwayCommons; P13521; -. DR Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs). DR Reactome; R-HSA-8957275; Post-translational protein phosphorylation. DR SignaLink; P13521; -. DR BioGRID-ORCS; 7857; 13 hits in 1146 CRISPR screens. DR ChiTaRS; SCG2; human. DR GeneWiki; SCG2; -. DR GenomeRNAi; 7857; -. DR Pharos; P13521; Tbio. DR PRO; PR:P13521; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; P13521; Protein. DR Bgee; ENSG00000171951; Expressed in type B pancreatic cell and 146 other cell types or tissues. DR ExpressionAtlas; P13521; baseline and differential. DR GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; IDA:HGNC-UCL. DR GO; GO:0098992; C:neuronal dense core vesicle; IEA:Ensembl. DR GO; GO:0030141; C:secretory granule; IBA:GO_Central. DR GO; GO:0042056; F:chemoattractant activity; IDA:HGNC-UCL. DR GO; GO:0005125; F:cytokine activity; IDA:HGNC-UCL. DR GO; GO:0001525; P:angiogenesis; IDA:HGNC-UCL. DR GO; GO:0043542; P:endothelial cell migration; TAS:HGNC-UCL. DR GO; GO:0048245; P:eosinophil chemotaxis; IDA:HGNC-UCL. DR GO; GO:0050930; P:induction of positive chemotaxis; IDA:HGNC-UCL. DR GO; GO:0006954; P:inflammatory response; TAS:HGNC-UCL. DR GO; GO:0035556; P:intracellular signal transduction; IDA:HGNC-UCL. DR GO; GO:0000165; P:MAPK cascade; IDA:HGNC-UCL. DR GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:BHF-UCL. DR GO; GO:0001937; P:negative regulation of endothelial cell proliferation; TAS:HGNC-UCL. DR GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL. DR GO; GO:0050918; P:positive chemotaxis; IDA:BHF-UCL. DR GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:HGNC-UCL. DR GO; GO:0009306; P:protein secretion; TAS:ProtInc. DR InterPro; IPR018054; Chromogranin_CS. DR InterPro; IPR001990; Granin. DR InterPro; IPR038858; ScgII. DR PANTHER; PTHR15119; SECRETOGRANIN II; 1. DR PANTHER; PTHR15119:SF0; SECRETOGRANIN-2; 1. DR Pfam; PF01271; Granin; 1. DR PROSITE; PS00422; GRANINS_1; 1. DR Genevisible; P13521; HS. PE 1: Evidence at protein level; KW Calcium; Cleavage on pair of basic residues; Glycoprotein; Phosphoprotein; KW Reference proteome; Secreted; Signal; Sulfation. FT SIGNAL 1..27 FT /evidence="ECO:0000255" FT PROPEP 28..30 FT /evidence="ECO:0000255" FT /id="PRO_0000005452" FT CHAIN 31..617 FT /note="Secretogranin-2" FT /id="PRO_0000005453" FT PEPTIDE 182..214 FT /note="Secretoneurin" FT /evidence="ECO:0000250|UniProtKB:P30945" FT /id="PRO_0000005454" FT PEPTIDE 527..566 FT /note="Manserin" FT /evidence="ECO:0000250|UniProtKB:P10362" FT /id="PRO_0000432735" FT REGION 120..143 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 182..200 FT /note="O-glycosylated at one site" FT REGION 257..302 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 552..583 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 151 FT /note="Sulfotyrosine" FT /evidence="ECO:0000269|PubMed:2745426" FT MOD_RES 174 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P10362" FT MOD_RES 268 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P10362" FT MOD_RES 432 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P10362" FT MOD_RES 532 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q03517" FT MOD_RES 555 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q03517" FT MOD_RES 556 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q03517" FT VARIANT 61 FT /note="Y -> H (in dbSNP:rs16864976)" FT /id="VAR_031555" FT VARIANT 196 FT /note="A -> V (in dbSNP:rs1438157)" FT /id="VAR_048755" FT VARIANT 294 FT /note="D -> G (in dbSNP:rs17852053)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_031556" FT VARIANT 421 FT /note="R -> G (in dbSNP:rs17856669)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_031557" FT VARIANT 535 FT /note="D -> G (in dbSNP:rs17852054)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_031558" FT VARIANT 564 FT /note="P -> L (in dbSNP:rs36043001)" FT /id="VAR_031559" FT CONFLICT 273 FT /note="E -> G (in Ref. 1; AAA36607)" FT /evidence="ECO:0000305" SQ SEQUENCE 617 AA; 70941 MW; A81C9C091DE9DF6B CRC64; MAEAKTHWLG AALSLIPLIF LISGAEAASF QRNQLLQKEP DLRLENVQKF PSPEMIRALE YIENLRQQAH KEESSPDYNP YQGVSVPLQQ KENGDESHLP ERDSLSEEDW MRIILEALRQ AENEPQSAPK ENKPYALNSE KNFPMDMSDD YETQQWPERK LKHMQFPPMY EENSRDNPFK RTNEIVEEQY TPQSLATLES VFQELGKLTG PNNQKRERMD EEQKLYTDDE DDIYKANNIA YEDVVGGEDW NPVEEKIESQ TQEEVRDSKE NIEKNEQIND EMKRSGQLGI QEEDLRKESK DQLSDDVSKV IAYLKRLVNA AGSGRLQNGQ NGERATRLFE KPLDSQSIYQ LIEISRNLQI PPEDLIEMLK TGEKPNGSVE PERELDLPVD LDDISEADLD HPDLFQNRML SKSGYPKTPG RAGTEALPDG LSVEDILNLL GMESAANQKT SYFPNPYNQE KVLPRLPYGA GRSRSNQLPK AAWIPHVENR QMAYENLNDK DQELGEYLAR MLVKYPEIIN SNQVKRVPGQ GSSEDDLQEE EQIEQAIKEH LNQGSSQETD KLAPVSKRFP VGPPKNDDTP NRQYWDEDLL MKVLEYLNQE KAEKGREHIA KRAMENM //